Mavrilimumab Biosimilar - Research Grade
Product Specifications
UniProt
P04141
Reactivity
Human
Target
GM-CSF
Sequence
https://www.imgt.org/mAb-DB/
Applications
Functional Assays
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
5mg/mL
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE
Buffer
ICH3002
Shipping Conditions
Blue ice
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Fragment
Human IgG1-Lambda2
Specificity
Detects human GM-CSF. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Mavrilimumab.
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Applications Notes
This biosimilar is for research use only (RUO) : it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Isotype Control
Bulk Human IgG1 Isotype Control (IB1) [ICH2254]
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
C19orf69 (ERICH4) (NM_001130514) Human Over-expression Lysate
Anti-BC2-tag - DyLight® 488 conjugated (40 µg)
